MedMeetings – Translate Knowledge Into the Practice

EASD 2025

Mortality, Kidney, and Safety Outcomes with SGLT-2 Inhibitors vs DPP4 Inhibitors in Patients with Type 2 Diabetes Treated with Systemic Glucocorticoids

The research study was presented on Monday, September 15th, 2025

Mukul Ayachit January 23, 2026

EASD 2025

Precision Medicine in Type 2 Diabetes: Targeting GLP1 Receptor Agonist and SGLT-2 Inhibitor Combination Treatment for Kidney Protection

The comprehensive study was presented on Monday, September 15th, 2025

Mukul Ayachit January 22, 2026

EASD 2025

Sustained Impact of Dapagliflozin on Epicardial Fat Thickness in Type 2 Diabetes: Insights from the DAPAHEART 4-Year Experience

The groundbreaking study was presented on Monday, September 15th, 2025

Mukul Ayachit January 20, 2026

EASD 2025

Achievement of Target CGM Metrics in People with Type 1 Diabetes Treated with Zimislecel (VX-880) in the FORWARD Study

The trial study was presented on Tuesday, September 16th, 2025

Mukul Ayachit January 13, 2026

EASD 2025

Bridging the Gaps in Diabetic Ketoacidosis Management: Real-World Experience of Protocol Adherence and Outcomes in a Major UK Centre

The research study was presented on Tuesday, September 16th, 2025

Mukul Ayachit January 12, 2026

EASD 2025

Overweight, Obesity, and Glycemic Control: Iinsights from the T1D Exchange Registry

The comprehensive study was presented on Tuesday, September 16th, 2025

Mukul Ayachit January 9, 2026

Latest Articles

Societies

Speciality